Literature DB >> 16249175

The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development.

Angeliki Malliri1, Tomasz P Rygiel, Rob A van der Kammen, Ji-Ying Song, Rainer Engers, Adam F L Hurlstone, Hans Clevers, John G Collard.   

Abstract

Mutations in the canonical Wnt signaling pathway leading to its activation are known to cause the majority of intestinal tumors. However, few genes targeted by this pathway have been demonstrated to affect tumor development in vivo. Here we show that Tiam1, a selective Rac GTPase activator, is a Wnt-responsive gene expressed in the base of intestinal crypts and up-regulated in mouse intestinal tumors and human colon adenomas. Moreover, by comparing tumor development in APC mutant Min (multiple intestinal neoplasia) mice expressing or lacking Tiam1, we found that Tiam1 deficiency significantly reduces the formation and growth of polyps in vivo. However, invasion of malignant intestinal tumors is enhanced by a lack of Tiam1. In line with this, knock-down of Tiam1 reduced the growth potential of human colorectal cancer cells and their ability to form E-cadherin-based adhesions, a prerequisite for local invasion of tumor cells. Our data indicate a novel cross-talk between Tiam1-Rac and canonical Wnt-signaling pathways that influences intestinal tumor formation and progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249175     DOI: 10.1074/jbc.M507582200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.

Authors:  Charisa L Cottonham; Satoshi Kaneko; Lan Xu
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

Review 2.  The canonical Wnt signalling pathway and its APC partner in colon cancer development.

Authors:  Jean Schneikert; Jürgen Behrens
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

3.  Giving APCmin tumours a SPARC.

Authors:  Alex Gregorieff; Hans Clevers
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

4.  Small GTPase protein Rac-1 is activated with maturation and regulates cell morphology and function in chondrocytes.

Authors:  Bethany A Kerr; Tomohiro Otani; Eiki Koyama; Theresa A Freeman; Motomi Enomoto-Iwamoto
Journal:  Exp Cell Res       Date:  2008-01-18       Impact factor: 3.905

Review 5.  Rho GTPases: functions and association with cancer.

Authors:  Saskia I J Ellenbroek; John G Collard
Journal:  Clin Exp Metastasis       Date:  2007-11-14       Impact factor: 5.150

6.  An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis.

Authors:  G Zhu; Z Fan; M Ding; H Zhang; L Mu; Y Ding; Y Zhang; B Jia; L Chen; Z Chang; W Wu
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

7.  The role of fibroblast Tiam1 in tumor cell invasion and metastasis.

Authors:  K Xu; S Rajagopal; I Klebba; S Dong; Y Ji; J Liu; C Kuperwasser; J A Garlick; S P Naber; R J Buchsbaum
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

8.  A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells.

Authors:  Carolina Espina; María Virtudes Céspedes; Miguel Angel García-Cabezas; María Teresa Gómez del Pulgar; Alicia Boluda; Lourdes García Oroz; Salvador A Benitah; Paloma Cejas; Manuel Nistal; Ramón Mangues; Juan Carlos Lacal
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

9.  Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.

Authors:  Feijun Luo; David G Brooks; Hongtao Ye; Rifat Hamoudi; George Poulogiannis; Charles E Patek; Douglas J Winton; Mark J Arends
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

10.  The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module.

Authors:  Shin-ichi Terawaki; Ken Kitano; Tomoyuki Mori; Yan Zhai; Yoshiki Higuchi; Norimichi Itoh; Takashi Watanabe; Kozo Kaibuchi; Toshio Hakoshima
Journal:  EMBO J       Date:  2009-11-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.